Product Information
LEVORPHANOL 2 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $10.6456 per EA under NDC 00054043825. Its NADAC has been published 193 times since Sep 17, 2014.
FDA first approved this application on Mar 31, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054043825
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
LEVORPHANOL TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA074278FDA Approved
3/31/2000
TE Code
AB
On Market Since
3/31/2000
Pharmacological Classes
Price Statistics
The NADAC for LEVORPHANOL 2 MG TABLET has been published 193 times since Sep 17, 2014, and over the history we have for it it has risen 569.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.6456 per EA |
|---|---|
| All-time high | $20.2966 (May 14, 2025) |
| All-time low | $1.5543 (Feb 18, 2015) |
| 52-week high | $16.1179 |
| 52-week low | $10.6456 |
| Median price | $10.6456 |
| Average price | $8.5128 |
| Largest weekly change | +900.6% (Apr 17, 2024) |
| Weeks tracked | 193 |
| Tracking since | Sep 17, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the LEVORPHANOL TARTRATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
LEVORPHANOL TARTRATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVORPHANOL 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVORPHANOL 2 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $10.6456 per EA (NDC 00054043825), effective Sep 30, 2026.
How has the price of LEVORPHANOL 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVORPHANOL 2 MG TABLET has risen 569.7%. It has been tracked across 193 weekly CMS publications since Sep 17, 2014.
What are the highest and lowest recorded NADAC prices for LEVORPHANOL 2 MG TABLET?
Since Sep 17, 2014, the NADAC for LEVORPHANOL 2 MG TABLET has ranged from a low of $1.5543 (Feb 18, 2015) to a high of $20.2966 (May 14, 2025), with a median of $10.6456 per EA.
Are there cheaper alternatives to LEVORPHANOL 2 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of LEVORPHANOL 2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LEVORPHANOL 2 MG TABLET?
LEVORPHANOL 2 MG TABLET (NDC 00054043825) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.